Literature DB >> 33982755

Reply to letter by Schwartz et al.

Markus Kuksis1, Yizhuo Gao2, Alex Kiss3, Katarzyna J Jerzak4.   

Abstract

Entities:  

Year:  2021        PMID： 33982755      PMCID： PMC8328035          DOI： 10.1093/neuonc/noab078

Source DB:  PubMed          Journal:  Neuro Oncol        ISSN： 1522-8517            Impact factor:   12.300


× No keyword cloud information.
  4 in total

1.  A Prospective Randomised Phase III Clinical Trial Testing the Role of Prophylactic Cranial Radiotherapy in Patients Treated with Trastuzumab for Metastatic Breast Cancer - Anglo Celtic VII.

Authors:  P Canney; E Murray; J Dixon-Hughes; L-A Lewsley; J Paul
Journal:  Clin Oncol (R Coll Radiol)       Date:  2015-05-11       Impact factor: 4.126

2.  Incidence of Brain Metastases in Nonmetastatic and Metastatic Breast Cancer: Is There a Role for Screening?

Authors:  Adam S Komorowski; Ellen Warner; Helen J MacKay; Arjun Sahgal; Kathleen I Pritchard; Katarzyna J Jerzak
Journal:  Clin Breast Cancer       Date:  2019-07-11       Impact factor: 3.225

3.  Neratinib Plus Paclitaxel vs Trastuzumab Plus Paclitaxel in Previously Untreated Metastatic ERBB2-Positive Breast Cancer: The NEfERT-T Randomized Clinical Trial.

Authors:  Ahmad Awada; Ramon Colomer; Kenichi Inoue; Igor Bondarenko; Rajendra A Badwe; Georgia Demetriou; Soo-Chin Lee; Ajay O Mehta; Sung-Bae Kim; Thomas Bachelot; Chanchal Goswami; Suryanarayan Deo; Ron Bose; Alvin Wong; Feng Xu; Bin Yao; Richard Bryce; Lisa A Carey
Journal:  JAMA Oncol       Date:  2016-12-01       Impact factor: 31.777

4.  The incidence of brain metastases among patients with metastatic breast cancer: a systematic review and meta-analysis.

Authors:  Markus Kuksis; Yizhuo Gao; William Tran; Christianne Hoey; Alex Kiss; Adam S Komorowski; Aman J Dhaliwal; Arjun Sahgal; Sunit Das; Kelvin K Chan; Katarzyna J Jerzak
Journal:  Neuro Oncol       Date:  2021-06-01       Impact factor: 12.300
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.